[Possible uses of Convulsofin liquid in the treatment of pediatric epilepsies].
The effect of Convulsofin-liquidum on several epilepsies and types of seizure in childhood is described. Typical and atypical absences, tonic-clonic seizures of primary generalised epilepsies as well as atonic or myoclonic seizures are considered to be the main indications for the treatment with Convulsofin. To the special advantage of the application in drops especially with infants is referred.
D000284:Administration, Oral; D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D004831:Epilepsies, Myoclonic / Q000188:drug therapy; D004828:Epilepsies, Partial / Q000188:drug therapy; D004827:Epilepsy / Q000188:drug therapy*; D004832:Epilepsy, Absence / Q000188:drug therapy; D004833:Epilepsy, Temporal Lobe / Q000188:drug therapy; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy; D006801:Humans; D007223:Infant; D003294:Seizures, Febrile / Q000188:drug therapy; D014635:Valproic Acid / Q000627:therapeutic use*
D014635:Valproic Acid
Einsatzmöglichkeiten von Convulsofin-liquidum bei der Behandlung kindlicher Epilepsien.